Maharashtra crane accident: PM Modi expresses grief, announces Rs 2 lakh ex-gratia for kin of deceased

-

Prime Minister Narendra Modi on Tuesday condoled the loss of lives in the tragic accident that killed 16 workers and injured three after a crane fell on a bridge slab during construction of the third phase of Samruddhi Expressway in Shahapur tehsil of Thane district on Tuesday.

The PM announced an ex-gratia of Rs 2 lakh for the next of kin of each of the deceased and an assistance of Rs 50,000 for the injured.

The Prime Minister’s Office in a tweet said, “Pained by the tragic mishap in Shahapur, Maharashtra. My deepest condolences to the families of those who lost their lives. Our thoughts and prayers are with those who are injured. NDRF and local administration are working at the site of the mishap and all possible measures are being taken to ensure proper assistance to those affected.”

“An ex-gratia of Rs. 2 lakh from PMNRF will be given to the next of kin of each deceased. The injured would be given Rs. 50,000,” the tweet said.

Three to five persons are still feared trapped and efforts are on to rescue them, an NDRF official said.

The injured have been shifted to nearby hospital, he added.

It was a special-purpose mobile gantry crane used in bridge construction and to install precast box girders in highway construction projects.

The accident took place shortly after midnight on Tuesday near Sarlambe village in Shahapur tehsil, around 80 km from Mumbai, the official said.

Meanwhile, Maharashtra CM Eknath Shinde also announced Rs 5 lakh ex-gratia for the next of kin of the deceased.

“Rs 5 lakhs ex-gratia will be given to the next of kin of the deceased. It is an unfortunate incident. A company based in Switzerland was working here. Instructions have been given for its thorough investigation. The NDRF team has reached the spot and has given instructions for rescue work. Our concern department officials and minister are present at the spot,” said the Chief Minister.

With inputs from agencies



from Firstpost India Latest News https://ift.tt/PGIiNZK
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more